These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7862876)

  • 1. Neuroendocrine effects of sumatriptan.
    Herdman JR; Delva NJ; Hockney RE; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):561-4. PubMed ID: 7862876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal 5-HT1D receptor function in cluster headache: a neuroendocrine study with sumatriptan.
    Pinessi L; Rainero I; Valfrè W; Lo Giudice R; Ferrero M; Rivoiro C; Arvat E; Gianotti L; Del Rizzo P; Limone P
    Cephalalgia; 2003 Jun; 23(5):354-60. PubMed ID: 12780765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactin.
    de Rezende MG; Garcia-Leal C; Graeff FG; Del-Ben CM
    J Psychopharmacol; 2013 Dec; 27(12):1124-33. PubMed ID: 23325368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine.
    Rainero I; Valfrè W; Savi L; Gentile S; Pinessi L; Gianotti L; Arvat E; Ghigo E; Del Rizzo P; Calvelli P; Limone P
    J Endocrinol Invest; 2001 May; 24(5):310-4. PubMed ID: 11407649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose zolmitriptan as a 5-HT neuroendocrine challenge agent in humans.
    Moeller FG; Bjork JM; Dougherty DM; Van de Kar LD; Marsh DM; Swann AC
    Psychoneuroendocrinology; 2000 Aug; 25(6):607-18. PubMed ID: 10840172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sumatriptan decreases food intake and increases plasma growth hormone in healthy women.
    Boeles S; Williams C; Campling GM; Goodall EM; Cowen PJ
    Psychopharmacology (Berl); 1997 Jan; 129(2):179-82. PubMed ID: 9040124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan challenge in bipolar patients with and without migraine: a neuroendocrine study of 5-HT1D receptor function.
    Mahmood T; Silverstone T; Connor R; Herbison P
    Int Clin Psychopharmacol; 2002 Jan; 17(1):33-6. PubMed ID: 11800504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors.
    Facchinetti F; Nappi RE; Sances G; Fioroni L; Nappi G; Genazzani AR
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):211-4. PubMed ID: 8137520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache.
    Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L
    Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of gepirone on neuroendocrine function and temperature in humans.
    Anderson IM; Cowen PJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1990; 100(4):498-503. PubMed ID: 2157231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
    Whale R; Bhagwagar Z; Cowen PJ
    Psychopharmacology (Berl); 1999 Jul; 145(2):223-6. PubMed ID: 10463324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine treatment and the prolactin response to sumatriptan.
    Wing YK; Clifford EM; Sheehan BD; Campling GM; Hockney RA; Cowen PJ
    Psychopharmacology (Berl); 1996 Apr; 124(4):377-9. PubMed ID: 8739554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan does not stimulate PRL and GH secretion in acromegaly.
    Cuttica CM; Sessarego P; Valenti S; Falivene MR; Giusti M; Giordano G
    Minerva Endocrinol; 1995 Jun; 20(2):141-4. PubMed ID: 8531896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan.
    Pallanti S; Bernardi S; Allen A; Hollander E
    J Psychopharmacol; 2010 Dec; 24(12):1802-9. PubMed ID: 19825906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of oral sumatriptan, a 5-HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man.
    Entwisle SJ; Fowler PA; Thomas M; Eckland DJ; Lettis S; York M; Freedman PS
    Br J Clin Pharmacol; 1995 Apr; 39(4):389-95. PubMed ID: 7640145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder.
    Pian KL; Westenberg HG; van Megen HJ; den Boer JA
    Psychopharmacology (Berl); 1998 Dec; 140(3):365-70. PubMed ID: 9877016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood.
    Riedel WJ; Klaassen T; Griez E; Honig A; Menheere PP; van Praag HM
    Neuropsychopharmacology; 2002 Mar; 26(3):358-67. PubMed ID: 11850150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
    Walsh AE; Ware CJ; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(4):568-72. PubMed ID: 1663254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients.
    Pinessi L; Rainero I; Savi L; Valfrè W; Limone P; Calvelli P; Del Rizzo P; Gianotti L; Taliano M; Ghigo E; Arvat E
    Cephalalgia; 2000 May; 20(4):223-7. PubMed ID: 10999671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.